Press Release

17 Nov

Posted at 13:01h in Press Release by
0 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text] IDENTIFY Study Results Published in PLOS ONE Washington DC—November 17, 2022—CorVista Health, Inc, a digital health company dedicated to improving cardiovascular disease diagnosis, announces the publishing of the IDENTIFY Study in PLOS ONE, the multicenter validation...

26 Oct

Posted at 16:15h in Press Release by
0 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text]Washington DC—October 25, 2022—CorVista Health, Inc, a digital health company dedicated to improving cardiovascular disease diagnosis, announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the CorVista System as a first...

08 Jun

Posted at 16:00h in Press Release by
0 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] Washington, DC, June 8, 2022 — CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the expansion of their Medical Advisory Board with the appointment of Drs. Vallerie V. McLaughlin and Mark G. Rabbat. ...

16 Feb

Posted at 16:00h in Press Release by
0 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text] Also Appointed to Board of Directors of The Forsyth Institute Washington, DC, February 16, 2022 — CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the election of Dr. Charles Bridges to the...

18 Jan

Posted at 08:30h in Press Release by
18 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]Washington, DC, January 18, 2022 — CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the appointment of Charles R. Bridges, M.D., Sc.D., as Executive Vice President and Chief Scientific Officer. In this...